A multicenter, open-label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myeloma (Q40197990)
Jump to navigation
Jump to search
scientific article published on 29 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter, open-label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myeloma |
scientific article published on 29 September 2014 |
Statements
1 reference
A multicenter, open-label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myeloma (English)
1 reference
Chuanying Geng
1 reference
Jian Hou
1 reference
Yaozhong Zhao
1 reference
Xiaoyan Ke
1 reference
Zhao Wang
1 reference
Lugui Qiu
1 reference
Hao Xi
1 reference
Fuxu Wang
1 reference
Na Wei
1 reference
Yan Liu
1 reference
Shifang Yang
1 reference
Peng Wei
1 reference
Xiangjun Zheng
1 reference
Zhongxia Huang
1 reference
Bing Zhu
1 reference
Wen-Ming Chen
1 reference
29 September 2014
1 reference
1 reference
1037-1042
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference